Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors

BACKGROUND: The success of immune checkpoint inhibitors has revolutionized cancer treatment options and triggered development of new complementary immunotherapeutic strategies, including T-cell co-stimulatory molecules, such as glucocorticoid-induced tumor necrosis factor receptor-related protein (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, R., Baxi, V., Li, Z., Locke, D., Hedvat, C., Sun, Y., Walsh, A.M., Shao, X., Basavanhally, T., Greenawalt, D.M., Patah, P., Novosiadly, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163007/
https://www.ncbi.nlm.nih.gov/pubmed/36863094
http://dx.doi.org/10.1016/j.esmoop.2023.100784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163007/
https://www.ncbi.nlm.nih.gov/pubmed/36863094
http://dx.doi.org/10.1016/j.esmoop.2023.100784

Ejemplares similares